Caribou Biosciences (CRBU) Return on Sales (2020 - 2026)
Caribou Biosciences (CRBU) reported Return on Sales of 0.11% for Q1 2026, up 7.0% year-over-year from 0.1% in Q1 2025, and down 51.86% on a QoQ basis from 0.07% in Q4 2025.
Caribou Biosciences (CRBU) has 7 years of Return on Sales data on file, last reported at 0.11% in Q1 2026.
- Quarterly Return on Sales rose 7.0% year-over-year to 0.11% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.12% (up 5.0% YoY) and the FY2025 annual result came in at 0.13%, up 2.0% from the prior year.
- Return on Sales retreated to 0.11% in Q1 2026 per CRBU's latest filing, from 0.07% in the prior quarter.
- Across five years, Return on Sales topped out at 0.01% in Q3 2023 and bottomed at 0.19% in Q1 2024.
- The 5-year median for Return on Sales is 0.11% (2023), against an average of 0.12%.
- The widest annual swing landed in 2024, when Return on Sales dropped 18 bps; it then rose 11 bps in 2025.
- Tracing CRBU's Return on Sales over 5 years: stood at 0.08% in 2022, then decreased by 27 bps to 0.11% in 2023, then sank by 78 bps to 0.19% in 2024, then soared by 61 bps to 0.07% in 2025, then slumped by 52 bps to 0.11% in 2026.
- Per Business Quant, the three latest CRBU Return on Sales figures stand at 0.11% (Q1 2026), 0.07% (Q4 2025), and 0.13% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.00% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 0.00% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.00% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 0.00% |
| 10 | Caribou Biosciences | 232.46 Mn | 114.84 Mn | - | -0.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.11% |
| Dec 31, 2025 | -0.07% |
| Sep 30, 2025 | -0.13% |
| Jun 30, 2025 | -0.18% |
| Mar 31, 2025 | -0.18% |
| Dec 31, 2024 | -0.19% |
| Sep 30, 2024 | -0.19% |
| Jun 30, 2024 | -0.13% |
| Mar 31, 2024 | -0.19% |
| Dec 31, 2023 | -0.11% |
| Sep 30, 2023 | -0.01% |
| Jun 30, 2023 | -0.09% |
| Mar 31, 2023 | -0.09% |
| Dec 31, 2022 | -0.08% |
| Sep 30, 2022 | -0.08% |
| Jun 30, 2022 | -0.07% |
| Mar 31, 2022 | -0.08% |
| Dec 31, 2021 | -0.07% |
| Sep 30, 2021 | -0.05% |
| Jun 30, 2021 | -0.10% |
| Mar 31, 2021 | -0.08% |
| Dec 31, 2020 | -0.15% |
| Sep 30, 2020 | -0.07% |
| Jun 30, 2020 | 0.00% |
| Mar 31, 2020 | -0.06% |